NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

J-TO,

Thanks for your predictions, but your post sounds extreme and a bit alarmist to me. I had to consult the detector on this one 😶 …




“This statement appears to be a weak attempt to persuade or manipulate and is unreliable for several reasons:

1. **Alarmist and Fear-Mongering Language**: Phrases like "gonna suffer a slaughter at the hands of these thieves" and "Nothing will stop them now" are designed to invoke fear and panic. This kind of alarmist language is often used to manipulate emotions rather than provide a reasoned analysis or sound opinion.

2. **Conspiracy Implication**: The claim that "They control the market" implies a conspiracy without providing evidence. Asserting market control by unspecified entities ("big bucks, always wins") is a common tactic in manipulative statements to create a sense of helplessness or inevitability.

3. **Speculative Predictions**: Predictions such as "huge dilution coming" and the stock "headed to the 50's next week" are speculative and presented without basis. Financial markets are complex and unpredictable, making such definitive predictions unreliable.

4. **Personal Opinion Presented as Fact**: The statement ends with "imo" (in my opinion), indicating that much of the preceding content is based on personal views rather than objective analysis.

5. **Negative Sentiment**: The overall tone is negative and defeatist ("HAPPY FRIGGIN NEW YEAR FELLOW BAG HOLDERS"), which can influence readers' perceptions and decisions negatively.

6. **Questionable Investment Advice**: Suggesting to "add if you got the balls to tie up your money for another 6 months to a year" is irresponsible as investment advice should be based on careful analysis, not on bravado or emotional responses to market conditions.

Overall, the statement appears to be more focused on stirring emotions and spreading negativity rather than providing a reliable, fact-based analysis or well-reasoned opinions.”

https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-that-a-marketing-authorization-application-has-been-submitted-to-the-uk-mhra-for-dcvax-l-for-glioblastoma-302021038.html